22.418 articles found

Prevention And Treatment of Synucleinopathic And Amyloidogenic Disease

SCHENK DALE B, GAMES KATE DORA, BUTTINI MANUEL J, CHILCOTE TAMIE J, ROCKENSTEIN EDWARD, MASLIAH ELIEZAR.

· 2007-08-20

Therapeutic Agents

GIORDANETTO FABRIZIO, INGHARDT TORD.

· 2007-08-17

Transgenic animal models of neurodegenerative diseases and their application to treatment development.

Rockenstein E, Crews L, Masliah E.

Adv Drug Deliv Rev · 2007-08-17

DOI: 10.1016/j.addr.2007.08.013PMID: 17869376

Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice.

Rommelfanger KS, Edwards GL, Freeman KG, Liles LC, Miller GW, Weinshenker D.

Proc Natl Acad Sci U S A · 2007-08-16

DOI: 10.1073/pnas.0702753104PMID: 17702867

Complications in subthalamic nucleus stimulation surgery for treatment of Parkinson's disease. Review of 272 procedures.

Seijo FJ, Alvarez-Vega MA, Gutierrez JC, Fdez-Glez F, Lozano B.

Acta Neurochir (Wien) · 2007-08-14

DOI: 10.1007/s00701-007-1267-1PMID: 17690838

Prolonged kynurenine 3-hydroxylase inhibition reduces development of levodopa-induced dyskinesias in parkinsonian monkeys.

Grégoire L, Rassoulpour A, Guidetti P, Samadi P, Bédard PJ, Izzo E, Schwarcz R, Di Paolo T.

Behav Brain Res · 2007-08-10

DOI: 10.1016/j.bbr.2007.08.007PMID: 17868931

Viewpoint: mechanisms of action and therapeutic potential of neurohormetic phytochemicals.

Mattson MP, Son TG, Camandola S.

Dose Response · 2007-08-06

DOI: 10.2203/dose-response.07-004.mattsonPMID: 18648607

Genetic findings in Parkinson's disease and translation into treatment: a leading role for mitochondria?

Bogaerts V, Theuns J, van Broeckhoven C.

Genes Brain Behav · 2007-08-03

DOI: 10.1111/j.1601-183x.2007.00342.xPMID: 17680806

Positive clinical data in Parkinson's and ischemia buoy gene therapy.

Sheridan C.

Nat Biotechnol · 2007-08-02

DOI: 10.1038/nbt0807-823PMID: 17687344

N-PHENYL-PRENYLAMINE DERIVATIVES FOR THE TREATMENT OF COGNITIVE, NEURODEGENERATIVE OR NEURONAL DISEASES OR DISORDERS

MARTINEZ GIL ANA, CASTRO MORERA ANA, MEDINA PADILLA MIGUEL, MUNOZ RUIZ PILAR, LOPEZ OGALLA JAVIER, GARCIA PALOMERO ESTHER, DE AUSTRIA DE LUQUE CELIA, USAN EGEA PAOLA, VALENZUELA LIMINANA RITA, GARCIA FERNANDEZ PABLO, DELGADO HERNANDEZ ELENA, PEREZ FERNANDEZ DANIEL IGNACIO.

· 2007-08-01

PHENYL-PRENYL-ETHER DERIVATIVES FOR THE TREATMENT OF COGNITIVE, NEURODEGENERATIVE OR NEURONAL DISEASES OR DISORDERS

MARTINEZ GIL ANA, CASTRO MORERA ANA, MEDINA PADILLA MIGUEL, MUNOZ RUIZ PILAR, LOPEZ OGALLA JAVIER, RUBIO ARRIETA LAURA, GARCIA PALOMERO ESTHER, GARCIA FERNANDEZ PABLO, DE AUSTRIA DE LUQUE CELIA, DELGADO HERNANDEZ ELENA, USAN EGEA PAOLA, VALENZUELA LIMINANA RITA.

· 2007-08-01

N-PHENYL-PRENYLAMINE DERIVATIVES FOR THE TREATMENT OF COGNITIVE, NEURODEGENERATIVE OR NEURONAL DISEASES OR DISORDERS

MARTINEZ GIL ANA, CASTRO MORERA ANA, MEDINA PADILLA MIGUEL, MUNOZ RUIZ PILAR, LOPEZ OGALLA JAVIER, GARCIA PALOMERO ESTHER, DE AUSTRIA DE LUQUE CELIA, USAN EGEA PAOLA, VALENZUELA LIMINANA RITA, GARCIA FERNANDEZ PABLO, DELGADO HERNANDEZ ELENA, PEREZ FERNANDEZ DANIEL IGNACIO.

· 2007-08-01